8alpha-hydroxy-4alpha,5alpha-epoxytaurin - Compound Card

8alpha-hydroxy-4alpha,5alpha-epoxytaurin

Select a section from the left sidebar

8alpha-hydroxy-4alpha,5alpha-epoxytaurin

Structure
Zoomed Structure
  • Family: Plantae - Asteraceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Sesquiterpene Glycoside
Canonical Smiles O[C@H]1C[C@@]2(C)C(=O)CC[C@@]3([C@@]2([C@@H]2[C@@H]1[C@H](C)C(=O)O2)O3)C
InChI InChI=1S/C15H20O5/c1-7-10-8(16)6-13(2)9(17)4-5-14(3)15(13,20-14)11(10)19-12(7)18/h7-8,10-11,16H,4-6H2,1-3H3/t7-,8-,10+,11-,13-,14+,15-/m0/s1
InChIKey NFLCPCZGVWLQKE-KSUCGKDGSA-N
Formula C15H20O5
HBA 5
HBD 1
MW 280.32
Rotatable Bonds 0
TPSA 76.13
LogP 0.83
Number Rings 4
Number Aromatic Rings 0
Heavy Atom Count 20
Formal Charge 0
Fraction CSP3 0.87
Exact Mass 280.13
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Artemisia herba-alba Asteraceae Plantae 72329

Showing of synonyms

  • Boriky D, Berrada M, et al. (1996). Eudesmanolides from Artemisia herba-alba.. Phytochemistry,1996,43(1),309-311. [View]
Pubchem: 101997931
Nmrshiftdb2: 70088435

No compound-protein relationship available.

Structure

SMILES: C123C(O3)CCC(=O)C2CCC4C1OC(=O)C4

Level: 0

Mol. Weight: 280.32 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.2
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.6
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.37

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.05
Plasma Protein Binding
27.58
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
13.3
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.15
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.01
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.73
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-2.46
Rat (Acute)
3.26
Rat (Chronic Oral)
1.49
Fathead Minnow
3.54
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
359.38
Hydration Free Energy
-8.32
Log(D) at pH=7.4
-0.31
Log(P)
0.33
Log S
-1.33
Log(Vapor Pressure)
-6.03
Melting Point
145.14
pKa Acid
5.26
pKa Basic
3.58
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Serpin domain-containing protein H0ZQY2 H0ZQY2_TAEGU Taeniopygia guttata 3 0.8249
Serpin domain-containing protein H0ZQY2 H0ZQY2_TAEGU Taeniopygia guttata 3 0.8249
11-beta-hydroxysteroid dehydrogenase 1 P28845 DHI1_HUMAN Homo sapiens 3 0.7960
11-beta-hydroxysteroid dehydrogenase 1 P28845 DHI1_HUMAN Homo sapiens 3 0.7960
Adenylate cyclase type 5 P30803 ADCY5_CANLF Canis lupus familiaris 3 0.7233
Adenylate cyclase type 5 P30803 ADCY5_CANLF Canis lupus familiaris 3 0.7233
Adenylate cyclase type 5 P30803 ADCY5_CANLF Canis lupus familiaris 3 0.7084
Adenylate cyclase type 5 P30803 ADCY5_CANLF Canis lupus familiaris 3 0.7084

Download SDF